Buy-rated reports

573 tickers rated Buy
Ranks this page's recent reports by score.
General Motors Company
GM·Consumer Discretionary
A ★★★★Buy
Current$77.20
Target$92.75
Return+20.1%
Oct 23, 2026

General Motors combines profitable North American trucks, strong automotive cash flow, and aggressive buybacks with a low forward earnings multiple, although commodity inflation, EV restructuring, and cyclical vehicle demand threaten earnings durability.

Score
81
Synchrony Financial
SYF·Financials
A ★★★★Buy
Current$75.09
Target$80.75
Return+7.5%
Oct 23, 2026

Synchrony's profitable merchant-financing franchise, strong capital returns, and modest earnings valuation offer attractive per-share value creation, although consumer credit losses and partner bargaining power constrain upside.

Score
76
Lockheed Martin Corporation
LMT·Industrials
A ★★★★Buy
Current$589.91
Target$627.00
Return+6.3%
Oct 23, 2026

Lockheed Martin offers durable defense franchises, record missile backlog and expanding cash-flow potential, although program-cost exposure and a valuation already reflecting stronger growth limit the margin of safety.

Score
79
Halliburton Company
HAL·Energy
A ★★★★Buy
Current$33.19
Target$38.40
Return+15.7%
Oct 23, 2026

Halliburton offers attractive exposure to international oilfield investment and potential margin recovery at a moderate valuation, although North American service oversupply and weak cash conversion remain substantial risks.

Score
76
Netflix, Inc.
NFLX·Communication Services
A ★★★★Buy
Current$67.08
Target$79.59
Return+18.6%
Oct 23, 2026

Netflix combines global streaming scale, durable pricing power and expanding profit margins with a more reasonable valuation, although advertising execution and rising content costs could constrain future cash-flow growth.

Score
80
Danaher Corporation
DHR·Healthcare
A ★★★★Buy
Current$229.75
Target$243.10
Return+5.8%
Oct 23, 2026

Danaher's high-switching-cost life sciences and diagnostics franchises can compound cash flow as bioprocessing demand recovers, but acquisition-related leverage and a demanding valuation limit its margin of safety.

Score
78
Intuitive Surgical, Inc.
ISRG·Healthcare
A ★★★★Buy
Current$443.85
Target$460.56
Return+3.8%
Oct 23, 2026

Intuitive Surgical combines a dominant robotic-surgery ecosystem with recurring procedure revenue and strong cash generation, but its premium valuation and planned instrument-pricing reductions constrain near-term upside.

Score
82
FB Financial Corporation
FBK·Financials
A ★★★★Buy
Current$52.10
Target$58.08
Return+11.5%
Oct 22, 2026

FB Financial offers profitable southeastern banking exposure at a modest forward earnings multiple, with organic loan growth and capital returns supporting upside, although deposit-cost pressure and rising nonperforming loans threaten earnings durability.

Score
75
ServisFirst Bancshares, Inc.
SFBS·Financials
A ★★★★Buy
Current$39.79
Target$46.80
Return+17.6%
Oct 22, 2026

ServisFirst offers highly efficient commercial banking, strong returns on equity, and an attractive earnings valuation, but deposit runoff and commercial credit exposure could undermine sustained earnings growth.

Score
82
RLI Corp.
RLI·Financials
A ★★★★Buy
Current$63.90
Target$68.00
Return+6.4%
Oct 22, 2026

RLI combines durable specialty-insurance underwriting, high capital efficiency, and shareholder-friendly distributions, but casualty-margin pressure and sensitivity to investment markets limit the near-term valuation upside.

Score
79
Commerce Bancshares, Inc.
CBSH·Financials
A ★★★★Buy
Current$55.15
Target$60.90
Return+10.4%
Oct 22, 2026

Commerce Bancshares combines strong regional banking returns, disciplined capital allocation, and expanding wealth fees at a reasonable valuation, though deposit competition and commercial credit risks could constrain earnings growth.

Score
81
BOK Financial Corporation
BOKF·Financials
A ★★★★Buy
Current$126.40
Target$138.00
Return+9.2%
Oct 22, 2026

BOK Financial offers an attractively priced regional banking franchise with improving interest margins, healthy credit quality, and meaningful capital returns, although deposit competition and cyclical commercial lending exposures could constrain earnings growth.

Score
78